NYSE:MDT', 'Medtronic plc', 'http://kldaily.com/kl-logo.png');

Factory Mutual Insurance Company Has Increased Position in Medtronic Plc (MDT) as Market Valuation Rose

December 11, 2017 - By Henry Gaston

Investors sentiment decreased to 0.9 in 2017 Q2. Its down 0.06, from 0.96 in 2017Q1. It dived, as 72 investors sold MDT shares while 449 reduced holdings. 99 funds opened positions while 370 raised stakes. 1.06 billion shares or 2.23% less from 1.08 billion shares in 2017Q1 were reported. Advisor Prtnrs Lc has 0.32% invested in Medtronic plc (NYSE:MDT). 151,265 are held by Lpl Fincl Limited Liability. Moreover, Schafer Cullen Capital Mgmt Inc has 0.1% invested in Medtronic plc (NYSE:MDT) for 94,289 shares. Prelude Capital Ltd Liability Corp invested in 31,341 shares. Wilkins Investment Counsel holds 90,000 shares or 2.54% of its portfolio. Laffer, a Tennessee-based fund reported 46,065 shares. Trustco Comml Bank N Y reported 17,077 shares stake. Calamos Advsrs Ltd Liability Corp invested in 381,465 shares. Choate accumulated 11,300 shares. Chilton Invest Company Ltd Liability Corp stated it has 26,842 shares or 0.09% of all its holdings. Ellington Mgmt Grp Incorporated Ltd Co has 3,000 shares. Ftb Advsrs has 5,165 shares for 0.05% of their portfolio. Wade G W & holds 4,367 shares or 0.05% of its portfolio. Zwj Invest Counsel has invested 0.06% in Medtronic plc (NYSE:MDT). Deutsche Natl Bank Ag stated it has 4.03 million shares or 0.26% of all its holdings.

Factory Mutual Insurance Company increased its stake in Medtronic Plc (MDT) by 3.89% based on its latest 2017Q2 regulatory filing with the SEC. Factory Mutual Insurance Company bought 40,000 shares as the company’s stock rose 5.51% with the market. The institutional investor held 1.07M shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q2, valued at $94.85 million, up from 1.03 million at the end of the previous reported quarter. Factory Mutual Insurance Company who had been investing in Medtronic Plc for a number of months, seems to be bullish on the $109.92B market cap company. The stock increased 0.18% or $0.145 during the last trading session, reaching $81.215. About 1.16M shares traded. Medtronic plc (NYSE:MDT) has risen 4.04% since December 11, 2016 and is uptrending. It has underperformed by 12.66% the S&P500.

Factory Mutual Insurance Company, which manages about $8.65B US Long portfolio, decreased its stake in Spdr Series Trust (XBI) by 83,900 shares to 236,000 shares, valued at $18.22M in 2017Q2, according to the filing. It also reduced its holding in Wyndham Worldwide Corp (NYSE:WYN) by 134,100 shares in the quarter, leaving it with 420,500 shares, and cut its stake in Envision Healthcare Corp.

Another recent and important Medtronic plc (NYSE:MDT) news was published by Nasdaq.com which published an article titled: “Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2018” on December 08, 2017.

Medtronic plc (NYSE:MDT) Ratings Coverage

Among 27 analysts covering Medtronic (NYSE:MDT), 17 have Buy rating, 0 Sell and 10 Hold. Therefore 63% are positive. Medtronic had 74 analyst reports since August 10, 2015 according to SRatingsIntel. The firm has “Overweight” rating given on Wednesday, August 23 by Barclays Capital. The rating was maintained by Needham with “Buy” on Tuesday, September 5. The firm earned “Neutral” rating on Wednesday, June 1 by BTIG Research. The rating was maintained by Northland Capital on Friday, April 21 with “Hold”. RBC Capital Markets maintained the stock with “Buy” rating in Sunday, August 20 report. RBC Capital Markets maintained the stock with “Outperform” rating in Tuesday, September 29 report. The rating was maintained by Oppenheimer with “Buy” on Tuesday, July 18. Needham maintained the shares of MDT in report on Tuesday, June 7 with “Buy” rating. SunTrust maintained it with “Buy” rating and $98 target in Monday, June 13 report. The firm has “Neutral” rating by Guggenheim given on Thursday, June 9.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.